Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Back
Association details:
Biomarker:
No biomarker
Cancer:
Gallbladder Cancer
Drug:
5-fluorouracil
(
Thymidylate synthase inhibitor
)
Direction:
Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
NCCN
Excerpt:
Neoadjuvant therapy (for gallbladder cancer only)…Other recommended regimens…single agents…5-fluorouracil
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
ESMO.org
Excerpt:
Gallbladder cancer... the recommended dose of radiotherapy is 45 Gy in fractions of 1.8 or 2 Gy with concurrent 5-fluorouracil (5-FU) or capecitabine [IV,C].
DOI:
10.1093/annonc/mdw324
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login